Patents by Inventor Charles H. Reynolds

Charles H. Reynolds has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230286997
    Abstract: Provided herein are compounds that inhibit the phosphorylation of MAPK and thus are useful in compositions and methods for treating cancer and inflammatory disease.
    Type: Application
    Filed: October 28, 2022
    Publication date: September 14, 2023
    Inventors: Yaron R. Hadari, Luca Carta, Michael Schmertzler, Theresa M. Williams, Charles H. Reynolds
  • Publication number: 20230211679
    Abstract: An electric vehicle (EV) charging system includes a number of output connections (e.g., cables). Each of the output connections is connected to at least one head, and each head can be connected concurrently to an EV. A controller can direct a charging current, delivered over a dedicated circuit from an electric power supply, to a first one of the output connections if a first EV is connected to a head connected to the first one of the output connections. Then, the charging current to the first one of the output connections can be stopped, switched to a second one of the output connections, and restarted if a second EV is connected to a head connected to the second one of the output connections.
    Type: Application
    Filed: February 28, 2023
    Publication date: July 6, 2023
    Inventors: Charles H. REYNOLDS, Ronald L. SILORIO
  • Publication number: 20230149369
    Abstract: Provided herein are methods and compositions for treating cancers, inflammatory diseases, rasopathies, and fibrotic disease involving aberrant Ras superfamily signaling through the binding of compounds to the GTP binding domain of Ras superfamily proteins including, in certain cases, K-Ras and mutants thereof, and a novel method for assaying such compositions.
    Type: Application
    Filed: June 28, 2022
    Publication date: May 18, 2023
    Inventors: Yaron R. Hadari, Luca Carta, Michael Schmertzler, Theresa M. Williams, Charles H. Reynolds, Rebecca Hutcheson
  • Publication number: 20230078755
    Abstract: Provided herein are methods and compositions for treating cancers, inflammatory diseases, rasopathies, and fibrotic disease involving aberrant Ras superfamily signaling through the binding of compounds to the GTP binding domain of Ras superfamily proteins including, in certain cases, K-Ras and mutants thereof, and a method for assaying such compositions.
    Type: Application
    Filed: December 18, 2019
    Publication date: March 16, 2023
    Inventors: Yaron R. Hadari, Michael Schmertzler, Theresa M. Williams, Luca Carta, Rebecca Hutcheson, Charles H. Reynolds
  • Patent number: 11590851
    Abstract: An electric vehicle (EV) charging system includes a number of output connections (e.g., cables). Each of the output connections is connected to at least one head, and each head can be connected concurrently to an EV. A controller can direct a charging current, delivered over a dedicated circuit from an electric power supply, to a first one of the output connections if a first EV is connected to a head connected to the first one of the output connections. Then, the charging current to the first one of the output connections can be stopped, switched to a second one of the output connections, and restarted if a second EV is connected to a head connected to the second one of the output connections.
    Type: Grant
    Filed: September 15, 2020
    Date of Patent: February 28, 2023
    Assignee: CyberSwitchingPatents, LLC.
    Inventors: Charles H. Reynolds, Ronald L. Silorio
  • Patent number: 11560390
    Abstract: Provided herein are compounds that inhibit the phosphorylation of MAPK and thus are useful in compositions and methods for treating cancer and inflammatory disease.
    Type: Grant
    Filed: September 16, 2020
    Date of Patent: January 24, 2023
    Assignee: SHY Therapeutics LLC
    Inventors: Yaron R. Hadari, Luca Carta, Michael Schmertzler, Theresa M. Williams, Charles H. Reynolds
  • Patent number: 11541041
    Abstract: Provided herein are methods and compositions for treating cancers, inflammatory diseases, rasopathies, and fibrotic disease involving aberrant Ras superfamily signaling through the binding of compounds to the GTP binding domain of Ras superfamily proteins including, in certain cases, K-Ras and mutants thereof, and a novel method for assaying such compositions.
    Type: Grant
    Filed: July 12, 2021
    Date of Patent: January 3, 2023
    Assignee: SHY Therapeutics LLC
    Inventors: Yaron R. Hadari, Luca Carta, Michael Schmertzler, Theresa M. Williams, Charles H. Reynolds, Rebecca Hutcheson
  • Publication number: 20220347162
    Abstract: Provided herein are methods and compositions for treating cancers, inflammatory diseases, rasopathies, and fibrotic disease involving aberrant Ras superfamily signaling through the binding of compounds to the GTP binding domain of Ras superfamily proteins including, in certain cases, K-Ras and mutants thereof, and a novel method for assaying such compositions.
    Type: Application
    Filed: January 6, 2021
    Publication date: November 3, 2022
    Inventors: Yaron R. Hadari, Luca Carta, Michael Schmertzler, Theresa M. Williams, Charles H. Reynolds, Rebecca Hutcheson
  • Publication number: 20220332725
    Abstract: Provided herein are compounds that inhibit the phosphorylation of MAPK and thus are useful in compositions and methods for treating cancer and inflammatory disease.
    Type: Application
    Filed: September 16, 2020
    Publication date: October 20, 2022
    Inventors: Yaron R. Hadari, Luca Carta, Michael Schmertzler, Theresa M. Williams, Charles H. Reynolds
  • Publication number: 20220080850
    Abstract: A controller includes a processor, memory, and two channels connected to the processor. The first channel and the second channel deliver charging current to charge an electric vehicle. The first channel is operable for delivering a first charging current to a first output connection having a first output head, and the second channel is operable for delivering power to a second controller that is operable for providing a second charging current to a second output connection having a second output head and a third output head.
    Type: Application
    Filed: November 23, 2021
    Publication date: March 17, 2022
    Inventors: Charles H. REYNOLDS, Ronald L. SILORIO
  • Patent number: 11213515
    Abstract: Provided herein are methods and compositions for treating cancers, inflammatory diseases, rasopathies, and fibrotic disease involving aberrant Ras superfamily signaling through the binding of compounds to the GTP binding domain of Ras superfamily proteins including, in certain cases, K-Ras and mutants thereof, and a novel method for assaying such compositions.
    Type: Grant
    Filed: January 6, 2021
    Date of Patent: January 4, 2022
    Assignee: SHY Therapeutics LLC
    Inventors: Yaron R. Hadari, Luca Carta, Michael Schmertzler, Theresa M. Williams, Charles H. Reynolds, Rebecca Hutcheson
  • Publication number: 20210387544
    Abstract: An electric vehicle (EV) charging system includes a number of output connections (e.g., cables). Each of the output connections is connected to at least one head, and each head can be connected concurrently to an EV. A charging current is directed to a first one of the output connections if a first EV is connected to a head connected to the first one of the output connections. Then, the charging current to the first one of the output connections can be stopped, switched to a second one of the output connections, and restarted if a second EV is connected to a head connected to the second one of the output connections. A graphical user interface (GUI) is rendered on the display of a computer system. The GUI includes elements that indicate which output connection of the charging station is receiving a charging current.
    Type: Application
    Filed: August 31, 2021
    Publication date: December 16, 2021
    Inventors: Charles H. REYNOLDS, Ronald L. SILORIO
  • Patent number: 11180034
    Abstract: A first controller can be coupled to a main power supply and deliver a first charging current to an electric vehicle (EV) at a first charging station. The first controller can also deliver power to a second controller that can provide a second charging current to an EV at a second charging station. The first controller turns off the power to the second controller in response to determining that there is an EV charging at the first charging station, and turns on the power to the second controller only in response to determining that an EV is not charging at the first charging station.
    Type: Grant
    Filed: October 27, 2017
    Date of Patent: November 23, 2021
    Assignee: CyberSwitchingPatents, LLC
    Inventors: Charles H. Reynolds, Ronald L. Silorio
  • Patent number: 11104246
    Abstract: An electric vehicle (EV) charging system includes a number of output connections (e.g., cables). Each of the output connections is connected to at least one head, and each head can be connected concurrently to an EV. A charging current is directed to a first one of the output connections if a first EV is connected to a head connected to the first one of the output connections. Then, the charging current to the first one of the output connections can be stopped, switched to a second one of the output connections, and restarted if a second EV is connected to a head connected to the second one of the output connections. A graphical user interface (GUI) is rendered on the display of a computer system. The GUI includes elements that indicate which output connection of the charging station is receiving a charging current.
    Type: Grant
    Filed: July 28, 2016
    Date of Patent: August 31, 2021
    Assignee: CYBER SWITCHING SOLUTIONS, INC.
    Inventors: Charles H. Reynolds, Ronald L. Silorio
  • Patent number: 11026930
    Abstract: Provided herein are methods and compositions for treating cancers, inflammatory diseases, rasopathies, and fibrotic disease involving aberrant Ras superfamily signaling through the binding of compounds to the GTP binding domain of Ras superfamily proteins including, in certain cases, K-Ras and mutants thereof, and a novel method for assaying such compositions.
    Type: Grant
    Filed: April 13, 2020
    Date of Patent: June 8, 2021
    Assignee: Shy Therapeutics LLC
    Inventors: Yaron R. Hadari, Luca Carta, Michael Schmertzler, Theresa M. Williams, Charles H. Reynolds, Rebecca Hutcheson
  • Patent number: 11000515
    Abstract: Provided herein are methods and compositions for treating cancers, inflammatory diseases, rasopathies, and fibrotic disease involving aberrant Ras superfamily signaling through the binding of compounds to the GTP binding domain of Ras superfamily proteins including, in certain cases, K-Ras and mutants thereof, and a novel method for assaying such compositions.
    Type: Grant
    Filed: October 16, 2019
    Date of Patent: May 11, 2021
    Assignee: Shy Therapeutics LLC
    Inventors: Yaron R. Hadari, Luca Carta, Michael Schmertzler, Theresa M. Williams, Charles H. Reynolds, Rebecca Hutcheson
  • Patent number: 10940139
    Abstract: Provided herein are methods and compositions for treating cancers, inflammatory diseases, rasopathies, and fibrotic disease involving aberrant Ras superfamily signaling through the binding of compounds to the GTP binding domain of Ras superfamily proteins including, in certain cases, K-Ras and mutants thereof, and a novel method for assaying such compositions.
    Type: Grant
    Filed: October 16, 2019
    Date of Patent: March 9, 2021
    Assignee: Shy Therapeutics LLC
    Inventors: Yaron R. Hadari, Luca Carta, Michael Schmertzler, Theresa M. Williams, Charles H. Reynolds, Rebecca Hutcheson
  • Patent number: 10933054
    Abstract: Provided herein are methods and compositions for treating cancers, inflammatory diseases, rasopathies, and fibrotic disease involving aberrant Ras superfamily signaling through the binding of compounds to the GTP binding domain of Ras superfamily proteins including, in certain cases, K-Ras and mutants thereof, and a novel method for assaying such compositions.
    Type: Grant
    Filed: October 16, 2019
    Date of Patent: March 2, 2021
    Assignee: Shy Therapeutics LLC
    Inventors: Yaron R. Hadari, Luca Carta, Michael Schmertzler, Theresa M. Williams, Charles H. Reynolds, Rebecca Hutcheson
  • Publication number: 20210001734
    Abstract: An electric vehicle (EV) charging system includes a number of output connections (e.g., cables). Each of the output connections is connected to at least one head, and each head can be connected concurrently to an EV. A controller can direct a charging current, delivered over a dedicated circuit from an electric power supply, to a first one of the output connections if a first EV is connected to a head connected to the first one of the output connections. Then, the charging current to the first one of the output connections can be stopped, switched to a second one of the output connections, and restarted if a second EV is connected to a head connected to the second one of the output connections.
    Type: Application
    Filed: September 15, 2020
    Publication date: January 7, 2021
    Inventors: Charles H. REYNOLDS, Ronald L. SILORIO
  • Publication number: 20210001735
    Abstract: A method of charging one or more electric vehicles (EVs) includes receiving a voltage over a dedicated circuit from an electric power supply. A charging current is generated using the voltage and directed to a first output connection if a first EV is connected to a head that is connected to the first output connection. The charging current to the first one of the output connections is stopped, then directed to a second output connection if a second EV is connected to a head coupled to the second output connection.
    Type: Application
    Filed: September 15, 2020
    Publication date: January 7, 2021
    Inventors: Charles H. REYNOLDS, Ronald L. SILORIO